International Stem Cell (ISCO) Preferred Dividend Payments (2010 - 2025)
International Stem Cell (ISCO) posted quarterly Preferred Dividend Payments of $28000.0 for Q3 2025, down 50.88% quarter-over-quarter from $57000.0 in Q2 2024.
International Stem Cell (ISCO) Preferred Dividend Payments (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Preferred Dividend Payments for 6 consecutive years, with $28000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Preferred Dividend Payments changed N/A year-over-year to $28000.0; the TTM figure through Sep 2025 stood at $256000.0 (changed N/A YoY), while the FY2012 annual figure was $1.4 million, up 419.77% from the prior year.
- Preferred Dividend Payments declined to $28000.0 in Q3 2025 per ISCO's latest filing, from $57000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $233000.0 in Q2 2023 and bottomed at -$62000.0 in Q3 2023.
- Historically, Preferred Dividend Payments has averaged $64000.0 across 3 years, with a median of $42500.0 in 2024.
- On a YoY basis, Preferred Dividend Payments climbed as much as 75.54% in 2024 and fell as far as 75.54% in 2024.
- International Stem Cell's Preferred Dividend Payments stood at -$62000.0 in 2023, then soared by 191.94% to $57000.0 in 2024, then tumbled by 50.88% to $28000.0 in 2025.
- Business Quant data shows ISCO's Preferred Dividend Payments at $28000.0 in Q3 2025, $57000.0 in Q2 2024, and -$62000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | 233,000.00 |
| Dec 31, 2012 | 1.25 Mn |
| Sep 30, 2012 | -93,000.00 |
| Jun 30, 2012 | 139,000.00 |
| Mar 31, 2012 | 82,000.00 |
| Dec 31, 2011 | -751,615.00 |
| Sep 30, 2011 | 108,384.00 |
| Jun 30, 2011 | 107,203.00 |
| Mar 31, 2011 | 106,000.00 |
| Dec 31, 2010 | -2.29 Mn |
| Sep 30, 2010 | 14,300.00 |